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Computational chemistry methods and tools have enabled studies of biological processes 
and chemical reactions to get insights from detailed atomic structures and reaction 
mechanisms. In this thesis, two biological problems are attacked by the classical force 
fields simulations and two homogeneous catalysis problems are studied by quantum 
chemical calculations. In all four problems, new insights have been revealed by the 
computational results. 
Chapter 1 briefly reviews the computational chemistry theories and methods developed and 
popularized in the past few decades. Chapter 2 addresses the protein-protein interaction 
problem in the onset of meningitis where E. coli OmpA interacts with FcγRI α-chain 
(FcγRIa) to invade macrophages. Computationally predicted three-dimensional structure of 
the OmpA-FcγRIa complex showed the role of three N-glycans in FcγRIa in the 
interaction. Chapter 3 studies the molecular origin of the bitter aftertaste of a kind of 
natural sweetener called steviol glycosides. By examining the predicted binding complexes 
between the human bitter taste receptors 2R4 and 2R14 which could be activated by steviol 
glycosides, a general activation model is proposed to explain the structure-function 
relationship and to predict new natural sweeteners with less bitterness. Chapter 4 
investigated the reaction mechanisms of methane to methanol conversion by a biomimetic 
tricopper cluster compound. An unusual exchange-stabilized multiradical state is found to 
be responsible for the hydrogen abstraction reactivity and a methyl radical rebound 
mechanism is proposed for methane oxidation. Calculations also show interesting spin 
crossing during the reaction cycle with high spin state forbidden for methyl rebound. 
Chapter 5 examines the reaction mechanisms in olefin hydrosilylation by the Pt-based 
Karstedt’s catalyst. An unexpected rate-determining step of agostic bond dissociation is 
found in between the elementary reaction steps proposed previously. The regioselectivity 
of the products are studied. An alternative reaction cycle which is kinetically unflavored is 
proposed. Oxygen stability is studied. 
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C h a p t e r  1  
INTRODUCTION 
Computational chemistry has advanced in the past decades to reach a stage that it acquired 
explanatory, descriptive, and even predictive power to chemical and biological problems, 
due to the development of new computational methods, simulation software, and computer 
technology. Various computational chemistry methods have been developed for physical 
problems at different time and length scales. Classical force fields have been developed for 
small organic molecules and later for macromolecules like proteins, allowing all-atom 
molecular dynamics simulations of protein folding events in explicit water solvent. Quantum 
chemistry methods, from wave-function based methods to density functional theory, have 
enabled routine energy calculations and geometry optimizations for molecules, solid, and 
interfaces up to 100 atoms. These methods have been used to understand protein dynamics 
and reaction mechanisms, and the hybrid of these methods has been developed to understand 
enzyme reactions. 
This chapter introduces the essence and the efficacy of the theories and applications of 
classical force field simulations and quantum chemistry computations.  
1. 1 Classical Force Fields Simulations 
Classical force fields simulations are based on the fundamental idea that the energy of a 
molecule could be represented as a function of its atomic coordinates. The exact energy 
surface on which the atoms move is the Born-Oppenheimer ground-state energy obtained 
from averaging the much-faster electronic motions. For macromolecules like proteins, it is 
not yet efficient to calculate such surfaces directly from quantum chemistry methods with 
high accuracy, thus approximations are made to use a set of simple classical functions to 
represent the energy, leading to practical “force field” methods to calculate the energy of 
systems of thousands to trillions of atoms and forces on individual atoms through molecular 




The parameters that go into the simple classical energy function terms in a force field are 
optimized in agreement with various sets of experimental data and also with accurate 
energies of small molecules calculated from quantum chemistry methods. The common force 
field for proteins has the following potential energy function: 
 𝑉 𝑟 = 𝑘%(𝑏 − 𝑏))+
%,-./
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    (1) 
The first two terms shown in equation (1) represent bond length stretching and bond angle 
bending as harmonic springs. The third term is the torsion term which could account for both 
the dihedral torsions and the improper torsions. The last term describes electrostatics via 
Coulomb’s law and the van der Waals interaction by a Lennard-Jones 6-12 potential. With 
different terms using different parameters which are transferable between molecules, one 
could calculate all static, dynamic, and thermodynamic properties of such molecular systems. 
A large number of force fields have been developed for simulating proteins. The earlier force 
fields include the ECEPP potentials from Scheraga2, the consistent force field (CFF) from 
Lifson3, and the potential energy functions of organic molecules from Allinger4. The current 
standard force fields for simulations of proteins include the Amber force fields5, the 
CHARMM force fields6, and the OPLS force fields7.   
1.2 Quantum Chemical Computations 
Quantum chemical methods aim to solve the electronic Schrodinger equation and calculate 
the electronic energy and other properties for a system of given nuclei positions and total 
number of electrons. To get the exact wave-function solution of the electronic Schrodinger 




number of electrons. There exist two ways to circumvent this “exponential curse”: one is to 
work with approximated wave-functions, the other is to work with electron densities.  
Wave-function based methods starts with a mean-field approximation called Hartree–Fock 
theory8, where a single Slater determinant is optimized variationally to approximate the exact 
wave-function, assuming each electron moves independently of all the other electrons except 
the Coulomb repulsion and the exchange interaction due to antisymmetrization. This method 
could calculate the molecular orbitals due to its independent particle approximation, but for 
the reason it does not include the correlations between electrons due to their instantaneous 
motions. To get a robust description of the electron correlation energy, more elaborate 
theoretical methods use Hartree-Fock results as a starting point to calculate correlated wave-
functions. These post-Hartree-Fock methods include second-order Moller-Plesset 
perturbation theory (MP2)9, methods based on the coupled-cluster ansatz10, and 
multireference methods such as Complete Active Space Self-Consistent Field (CASSCF)11. 
Instead of working with approximated wave-functions, density functional theory (DFT) 
works with electron density, which is a function of only three Cartesian coordinates as 
opposed to 3N coordinates of N electrons12. The Hohenberg–Kohn theorem13 establishes that 
there exists a universal mapping between the electron density and the electronic energy, in 
other words, that the total energy of the system is a functional of the electron density. Kohn 
and Sham14 offered a recipe of calculating the ground state energy by the virtue of 
Hohenberg-Kohn theorem, as shown in equations (2)-(4): 
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𝑣/ 𝑟 = 𝑣-LM 𝑟 + 𝑑V𝑟W
𝜌 𝑟W
𝑟 − 𝑟W + 𝑣NM 𝜌 𝑟  
 (4) 
A Kohn-Sham calculation uses a single Slater determinant function as an auxiliary wave-
function to calculate the non-interacting kinetic energy term Ts in equation (2), sweeping the 
kinetic part of the electron correlation energy in the Exc which is the exchange-correlation 
energy term that makes equation (2) exact. The so-called Hartree term U is the classical 
Coulomb energy, Vnuc is the electron-nuclei attraction energy. The single Slater determinant 
auxiliary orbitals are optimized in equation (3), which is the famous Kohn-Sham equation, 
and the Kohn-Sham potential vs is explicitly expressed in equation (4). Knowing the 
universal functional in Hohenberg–Kohn theorem is equivalent to knowing the form of 
functional Exc. 
There are two major schools of thoughts to approximate the exchange-correlation energy Exc. 
One school uses exact conditions required by quantum mechanics to derive the parameters 
so that their approximate functionals satisfy these exact conditions. This school of thought, 
pioneered by Perdew and Burke, has yielded successful functionals like PBE15 that is favored 
by physicists doing material calculations. The other school uses highly accurate results of 
specific systems, such as noble gas atoms, to fit the parameters in their approximated 
functionals. This school, lead by Becke, Parr and Yang, have generated functionals like 






C h a p t e r  2  
THE INTERACTION OF N-GLYCANS IN FC-GAMMA RECEPTOR I ALPHA 
CHAIN WITH ESCHERICHIA COLI K1 OUTER MEMBRANE PROTEIN A FOR 
ENTRY INTO MACROPHAGES 
 
Abstract 
Neonatal meningitis, due to Escherichia coli K1, is a serious central nervous system disease. 
It has been established that macrophages serve as permissive niches for E. coli K1 to multiply 
in the host and for attaining a threshold level of bacterial load, which is a pre-requisite for 
the onset of the disease. It has been demonstrated experimentally that three N-glycans in 
FcγRIa interact with OmpA of E. coli K1 for binding to and entering the macrophages. Our 
molecular dynamics and simulation studies predict that N-glycan 5 exhibits strong binding 
at the barrel site of OmpA formed by loops 3 and 4 while N-glycans 1 and 4 interact with the 
tip regions of the same loops. Molecular modeling data also suggest no role for the IgG 
binding site in the invasion process. In agreement, experimental mutations in IgG binding 
site had no effect on the E. coli K1 entry into macrophages in vitro or on the onset of 
meningitis in newborn mice. Together, this integration of experimental and computational 
studies reveals how the N-glycans in FcγRIa interact with the OmpA of E. coli K1 for 






In the event of bacterial invasion of host tissues, the intruder encounters an arsenal of host-
defense mechanisms, which result in either resolution of the pathogen by the host or 
subversion of the defense by the pathogen. Cross talk between host defense components is 
critical for successful resolution of the infection.  Macrophages are long-lived cells that play 
a critical role in engulfing pathogenic microorganisms and degrading them.  They express a 
range of receptors that recognize bacteria, including TLRs, Fc-γ receptors, complement 
receptors, scavenger receptors and mannose receptors18,19. Most microbial structures are 
recognized by more than one macrophage receptor and these receptors also interact with each 
other. Several pathogens subvert the anti-microbial mechanism by exploiting receptor 
interactions to create their own safe havens inside of which they survive.  The bacterial 
pathogens upon entering the host are coated with complement proteins enabling them to be 
recognized by complement receptors on the macrophages20.  Similarly, antibody coated 
bacterial recognition involves interaction with Fc- γ receptors, which subsequently elicits 
anti-microbial mechanisms.   A large number of bacteria introduce microbial factors that 
govern macrophage function by type III or type IV secretions systems18.  However, very few 
bacteria control the attack of macrophages at the receptor level.  One example is S. aureus, 
which uses protein A to bind to the Fc region of IgG, thus avoiding recognition by Fc-γ 
receptors21. 
Several studies have shown that FcγRI expression increases during septicemia and 
meningitis caused by a variety of bacteria.  The Fc region of IgG recognizes Fcγ receptors 
(FcγR) enabling it to play an important role in linking the cellular and humoral immune 
response. FcγR comprises a multigene family divided into 3 classes (FcγRI, II, and III), 
which are defined by their affinity for IgG. FcγRI is a transmembrane receptor that binds IgG 
with high affinity and induces the association of the γ-chain for signal transduction and 
triggering of effector responses such as macrophage phagocytosis. The ligation of FcγRI with 
IgG also mediates antibody dependent cellular cytotoxicity induced transcription of cytokine 
genes and release of inflammatory mediators.  It has been previously demonstrated that outer 




interacts with Fc-γ receptor I alpha chain (FcγRIa) to bind to and enter macrophages.  
Indeed, depletion of macrophages or lack of FcγRIa expression in macrophages in newborn 
mice renders the animals resistant to E. coli K1 induced meningitis. Despite the general 
requirement of FcγRIa association with the γ-chain for the internalization of the receptor, the 
interaction of OmpA+ E. coli with FcγRIa and the subsequent entry into macrophages does 
not require the γ-chain to facilitate E. coli K1 entry into macrophages, which is a novel 
mechanism. E. coli K1 interaction with macrophages in the absence of FcγRIa induces the 
expression of complement receptor 3 (CR3), which elicits antimicrobial mechanisms to kill 
the intracellular bacteria22. In addition, macrophages generate biopterin and neopterin upon 
E. coli K1 infection to suppress the production of nitric oxide and superoxide, respectively23. 
We showed previously that mutation of three amino acids in loops 1 and 3 of the extracellular 
domains of OmpA prevented the bacterial survival in macrophages.  Concomitantly, E. coli 
K1 containing a mutation in loop 1 could not cause meningitis in the newborn mouse 
model24.  However, there has been no molecular level understanding of how OmpA 
interaction with FcγRIa controls these cellular events. 
OmpA has been shown to interact with GlcNAc1-4GlcNAc epitopes of host receptors25,26. 
In addition, our previous molecular modeling predictions of OmpA interaction with 
GlcNAc1-4GlcNAc epitopes demonstrated that this moiety can bind to OmpA at two sites, 
one at the tip of loops 1 and 2, and the second at the barrel site formed by loops 3 and 422. 
We now report investigations on the role of N-glycans in FcγRIa in E. coli K1 entry of 
macrophages and for the onset of meningitis in the newborn mouse model.  The experimental 
studies show that N-glycosylation sites 1, 4, and 5 of FcγRIa are critical for interacting with 
OmpA of E. coli K1, both for binding to and entry of macrophages.  Adoptive transfer of 
FcγRIa-/- macrophages transfected with N-glycosylation (NG) mutants of FcγRIa into 
FcγRIa-/mice revealed that the presence of FcγRIa with 1, 4, or 5 NG sites are important for 
the onset of meningitis. To determine a structural basis for the experimental results, we 
conducted computer simulations to predict the atomistic structure for the OmpA protein 
complexed with the glycosylated FcγRIa, which identified how N-glycans contribute to the 




2.2 Simulation Details 
Protein-protein docking protocol: A hybrid docking strategy was adopted that first 
considered an ensemble of 15 protein conformations for OmpA, each of which was 
docked to FcγRIa to obtain an ensemble of 810,000 OmpA-FcγRIa protein-protein poses 
through exhaustive rotational and translational sampling of the relative position space 
that satisfies shape complementarity of the two given protein conformations. Then 
experimental observations and topological constraints were used to dramatically reduce 
the most likely poses to just a few that could be subjected to more detailed considerations 
including molecular dynamics. This strategy overcomes the limitations of finding scoring 
functions that can reliably rank the energies for protein-protein interactions and it reduces 
the issues regarding the conformational flexibility of glycosylated amino acids.  
 
First, an ensemble of 15 structures of OmpA that consider the flexibility of its four loops 
was predicted (Figure 2.1).  To construct this ensemble, (a) we selected as one candidate 
the PDB: 1BXW X-ray crystal structure of OmpA, which resolves more of the loop 
regions than the PDB: 1QJP X-ray crystal structure27,28.  (b) In addition, 2.5 nanosecond 
molecular dynamics (MD) simulation of the protein in explicit membrane and water 
(including salt) was carried out, starting from a conformation previously generated from 
the 1BXW X-ray crystal structure equilibrated with MD at 300K.  Here the protein was 
embedded in a periodically infinite box containing the 1-palmitoyl-2-
oleoylphosphatidylcholine (POPC) lipid system fully solvated with water and salt.  We 
used the CHARMM26 forcefield method for the lipid and OmpA protein and the TIP3P 




Solvate Plugin to solvate the protein at both the intracellular and extracellular regions 
was used32. All MD simulations used the NAMD program33 with the NPT constant 
temperature-pressure ensemble and periodic boundary conditions at 300K and 1 atm. 
From this trajectory 2500 conformations (1 snapshot every 1 picosecond) have been 
selected, which we clustered into 13 diverse structures using an RMSD Voronoi criterion 
of 1.5 Å from which we selected the 13 family heads.  (c) In addition, an ensemble of 10 
candidate structures based on distance-geometry fits to NMR (PDB number: 1G90)34 is 
available and their energies were minimized in vacuum using the DREIDING force 




Figure 2.1: 15 OmpA conformations for docking: 13 conformations from 1.5Å RMSD 
distance clustering of 2500 snapshots from 2.5ns MD (green), 1 X-ray crystal structure 
(orange, 1BXW), 1 NMR lowest DREIDING force field energy structure (magenta, 







These 15 OmpA conformations have a minimum RMSD diversity of 1.5Å in the loop 
regions.  Next, we examined the crystal structure of FcγRIa (PDB number: 3RJD)36. The 
interaction between the D1 and D2 fragments in the crystal is well defined (Figure 2.2A). 
Only the Ig-like domains D1 and D2 of the FcγRIa crystal structure were taken for 
docking purposes based on the experimental evidence about the N-glycosylation sites.  
Then the Man-Manβ1–4GlcNAc β1–4GlcNAcβ1 portion of N-glycans to each of the five 
N-glycosylation sites on D1 and D2 (residues 59, 78, 152, 159, and 163, predicted by 
NetNGlyc 1.0 Server) was added. Further, we relaxed the backbone of D1 and D2 with 
1ns MD in a solvent box of explicit water (including 154 mM NaCl or 0.9% w/w NaCl) 
while the side chains including the N-glycans were relaxed with 5ns of MD in explicit 
water. The snapshot closest to the average conformation was then chosen for docking 













Figure 2.2. (A) In the crystal packing of FcγR1, two neighboring D3 domains form 4 salt-
bridges, which may cause artifact in the conformation of D3 domain. (B) 5 N-
glycosylation sites in D1 and D2 domains of FcγR1. Glycan conformations are taken 
from the centroid conformation of 5ns MD trajectory. 
 
To describe the glycosylated Asn consistently with natural amino acids in the MD, the 
AMBER ff99SBildn (improved side-chain torsion potentials for the Amber ff99SB) 





















(GAFF) for the glycosylated Asn were used37,38. The Antechamber auxiliary program 
was used to prepare the GAFF library of the glycosylated Asn39. The TIP3P water model 
and the AmberTools40 including a terminal interface called tLEAP were used to add the 
ions and the water solvation box (http://ambermd.org/). 
 
Next, all 15 OmpA conformations were docked to the FcγRIa D1 and D2 structure using 
only the protein-protein complex pose generation part of ZDOCK41,42. The ZDOCK 
shape complementarity algorithm generated 54,000 complex poses with exhaustive 
rotational and translational sampling for each configuration of OmpA. Combining this 
with the 15 separate docking procedures yielded 810,000 complex poses (Table 2.1A).  
We then eliminated all poses in which FcγRIa would have a likely clash with the virtual 
membrane where OmpA is buried. This virtual membrane screening left us 496,100 
poses.  These poses were analyzed to determine which glycans and loops are involved in 
binding and the number of inter-protein salt-bridges within each pose (Figure 2.3). After 
eliminating poses that did not agree with the experimental evidence, we obtained 326 





Figure 2.3: For each protein-protein complex pose that has passed virtual membrane 
screening, we generated a 10-digit code that represents whether the five glycans of FcγR1 
(D1 and D2 only), the four OmpA loops and the FG loop of FcγR1 are involved in 
binding. If one of the above ten moieties (in the order it is mentioned) is involved in 
binding, the digit in the corresponding position is 1, otherwise it is 0. Also, the number of 
inter-protein salt-bridges and the residues that compose the salt-bridges are recorded for 
each pose. In this example, the analysis shows that glycan 2 and 4 (N78 and N156 
























Input code: ---------- 
(Use ‘-’ if binding is undetermined) 
Total  496100 /496100= 100% 
SB# POSE# ACCUM# POSE% ACCUM% 
17 2 2 0.00% 0.00% 
16 4 6 0.00% 0.00% 
15 14 20 0.00% 0.00% 
14 20 40 0.00% 0.01% 
13 71 111 0.01% 0.02% 
12 196 307 0.04% 0.06% 
11 428 735 0.09% 0.15% 
10 948 1683 0.19% 0.34% 
9 1886 3569 0.38% 0.72% 
8 4234 7803 0.85% 1.60% 
7 8211 16014 1.70% 3.20% 
6 15269 31283 3.10% 6.30% 
5 28897 60180 5.80% 12% 
4 53039 113219 11% 23% 
3 82712 195931 17% 39% 
2 103276 299207 21% 60% 
1 108100 407307 22% 82% 




Input code: 1--111-11- 
Info: Gylcan1,4,5, loop1,3,4 in binding 
Glycan2,3, loop2, loopFG undetermined 
Total     326 /496100= 0.066% 
SB# POSE# ACCUM# POSE% ACCUM% 
8 1 1 0.31% 0.31% 
7 4 5 1.20% 1.50% 
6 10 15 3.10% 4.60% 
5 38 53 12% 16% 
4 37 90 11% 28% 
3 69 159 21% 49% 




1 40 274 12% 84% 
0 52 326 16% 100% 
Table 2.1: The output files from using experimental results as an input to search for the 
matching poses. (A) If none of the ten pieces of experimental binding information is used 
(represented by ten ‘-’s as undetermined input), all 496100 poses in the pool would be 
selected. This is served as a sanity check of the code and algorithm. (B) The positive 
experimental binding information is used to select the matching poses. Input code ‘1--
111-11-’ means that FcγR1 N-glycan sites 1, 4, and 5 (‘1’s in first 5 digits), OmpA loops 
1, 3, and 4 (‘1’s in 6th to 9th digits) are involved in binding, while binding information of 
FcγR1 N-glycan sites 2 and 3, OmpA loop 2, and FG loop of FcγR1 are assumed as 
unknown. 
 
Poses matching experimental input: These 326 hits were then ranked by their number 
of inter-protein salt bridges, leading to one pose with a maximum of 8 salt-bridges 
(Figure 2.4). This pose of OmpA-FcγRIa (D1-D2 only) was selected as the structure 
likely to have the strongest protein-protein structure that is consistent with all 
experimental data. Then the D3 domain of FcγRIa as it is in the crystal structure was 
added and the consequent clashes between several loops were resolved by resampling the 
loop conformations using the DREIDING forcefield. This new structure is referred to as 
OmpA-FcγRIa for the remainder of the manuscript.  We then subjected this OmpA-
FcγRIa structure to 50 ns of NPT constant temperature-pressure ensemble at 300K and 1 
atm MD simulation in a periodic box with explicit lipid membrane (POPC) and explicit 
water with 154 mM NaCl, where the position of OmpA in the membrane is calculated 
according to the implicit solvent model of the lipid bilayer in the Orientations of Proteins 
in Membranes (OPM) database43. In order to allow the predicted pose to relax any strains 
that might arise in the newly formed protein-protein interface from our rigid-body 
docking procedure, we carried out molecular dynamics (MD) for 50 ns on the full system 




interactions between the subunits are maintained during the 50 ns of MD, indicating 
that the predicted protein-protein complex structure is stable (Table 2.2). 
 
      
                   8SB                                 7SBa                              7SBb 
       
              7SBc                                      7SBd  
 
Figure 2.4: Poses 8SB, 7SBa, 7SBb, 7SBc, and 7SBd have a similar overall binding 














OmpA FcγR1 Type of 
interaction 
Compare to experiments Suggested mutations  
(To combine mutations on 
both proteins) 






Salt-bridge OmpA loop 1c region is 
important for bacterial 
survival in microphage [1], 
thus is involved in binding 
FcγR1 








1a is involved in binding N27D  Increase 
binding 
3 LYS113  
(in loop3, 












Salt-bridge All-ALA mutant 4c (157-159 
on loop4) exhibited 
Bacterial survival ability in 
microphage, because salt-
bridge involving ARG156 
compensates the lost salt-
bridge by mutating ASP158 
to alanine 












Table 2.2: Specific interactions in the protein-protein interface of the best pose. 
 
2.3 Results and Discussion 
Molecular simulation of OmpA and glycosylated FcγRIa interaction supports that 
NG1, NG4 and NG5 sites are important for binding:  Based on the experimental data 
that NG sites 1, 4, and 5 in FcγRIa are critical to interacting with OmpA; simulation 
studies were performed to unravel molecular bases for this interaction. As described in 
experimental procedures, the FcγRIa structure was assembled initially using D1-D2 
domains and the D3 domain was added finally by resolving loop clashes (Figure 2.2). 
The orientation of NG sites 1 to 5 obtained from the centroid conformation of 5ns MD 
trajectory is shown in Figure 2.2. The modeling predicted a large number (810,000) of 




information from experiment (Table 2.1A). These structures were analyzed on the basis 
of the experiments to obtain 326 poses consistent with the experimental mutation studies 
(Table 2.1B). We then analyzed these to find that 1 led to 8 salt bridges, while 4 led to 7 
salt bridges, while all others had fewer (Figure 2.4). We found that 4 of these 5 structures 
were similar and chose the one with 8 salt bridges to examine in more detail. The 
resulting 3D structure supports interpretations of the experiments that N-glycan sites 1, 4, 
and 5 interact with OmpA. The transmembrane region of OmpA was then embedded in 
the POPC membrane with the rest of the complex and solvated in water. Then protein-
protein complex was then subjected to 50ns of MD simulation. The 50ns MD trajectory 
on the OmpA-FcγRIa complex led to stable and reasonable interactions for the 5 
important salt bridges, each of which remained stable during 50ns of MD (Figure 2.5, 
Table 2.2).  In addition to many new water-mediated hydrogen bonds showing up in the 
MD, we found that NG1 and NG5 formed direct non-covalent interactions with OmpA 
(Figure 2.6). Although NG4 is close to OmpA, the 50ns MD simulation of OmpA-FcγRIa 
did not lead to any direct interaction between the glycan of NG4 and OmpA (Figure 2.7). 
Instead the predicted NG4 conformation was locked into a hydrogen bond within FcγRIa 
between the side chain carbonyl group of Asn-159 and the backbone amino group of Ser-
161. This hydrogen bond remained stable during 50ns MD trajectory. This lack of 
interaction of NG4 with OmpA was inconsistent with the experimental data as lack of 
NG4 also prevented the bacterial invasion into macrophages. However, we speculated 
that the strong interaction with Asn 159 and Ser 161 might be accidental, caused by our 
initial configuration. To test this we rotated the side chain torsional angles of Asn-159 




degrees) to form direct interactions between NG4 and OmpA. This caused the 
hydrogen bond between Asn-159/Ser-161 to break, forming instead three new hydrogen 
bonds (one between carbonyl of Asn-159 side chain and backbone amino group of Ile-
160 within FcγRIa, and another two between the second GlcNAc moiety in NG4 and 
Asn-109 on loop 3 of OmpA). This new conformation of NG4 does not clash with any of 
the protein-protein interfacial peptides. We carried out 50 ns of simulation with this new 








Figure 2.5: N-linked glycans 1, 4, and 5 (grey) of D1 and D2 of FcγR1 are involved 
in binding OmpA. N-linked glycan 5 sticks into the β-barrel mouth of OmpA. OmpA 
forms salt-bridges in all corners with FcγR1, stabilizing the protein-protein interface 
(positively charged residue in blue, negatively charged in red). The IgG-binding loop 



















Figure 2.6: Glycans 1 forms a hydrogen bond with D149 of OmpA and is in proximity to 
N146 and R156 of OmpA to form water mediated hydrogen bonds. Glycan 5 is in the 
barrel binding pocket between loops 3 and 4 of OmpA and forms direct non-covalent 
interaction with W102, S120, A150, H151, T155, and P157 of OmpA. Glycan 5 could 
also form water-mediated interaction with D116, T106, and K107 of OmpA. Glycan 2 is 
too far away from OmpA and does not have any possibility to form direct or indirect 






Figure 2.7: NG4 does not form any direct non-covalent interactions with OmpA, but is in 








Figure 2.8: Rotating the torsional angles χ1 and χ2 can break the hydrogen bond between 
NG4 (silver conformation) and Ser-161 of FcγR1 (colored cyan), replaced by a new 
hydrogen bond between NG4 (salmon-color conformation) and Ile-160 of FcγR1, while 
also forming two more new hydrogen bonds that contribute to the direct interaction 
















The NG5 binding site in the barrel between loop 3 and loop 4 of OmpA predicted here 
coincides with the barrel binding site of GlcNAc1-4GlcNAc (chitobiose) epitopes 
predicted in our previous work in which we docked small ligand GlcNAc1-4GlcNAc 
(chitobiose) to OmpA22. To test how sensitive this barrel binding site is to the sugar unit 
when attached to the protein, we added the common N-glycan core sugar sequence 
Manβ1–4GlcNAcβ1–4GlcNAcβ1 to D1 and D2 domains of FcγRIa. In this predicted 
binding mode of the 3-sugar unit Man1-GlcNAc2 at the NG5 site, the two GlcNAc 
moieties maintain their interaction with OmpA as in GlcNAcβ1–4GlcNAc binding mode 
(Figure 2.6). Subsequently, the D3 domain and Manα1–6(Manα1–3)–Manβ1–
4GlcNAcβ1–4GlcNAcβ1 were also included in the minimization, which did not change 
the interaction of GlcNAcβ1–4GlcNAc with the OmpA.  This suggests that mannoses 
play a less important role than GlcNAc epitopes in N-glycan binding to OmpA, 
consistent with the previous experimental observations26. Taken together, the simulation 
studies support the experimental evidence that NG1, NG4 and NG5 interact with the 
loops 1, 3, and 4 of OmpA for binding, and provides a detailed 3D structure that can be 
used to better understand the nature of the protein-protein complex, which we expect will 




Recent developments in the application of dynamics and simulation have helped unravel 
temporal progress of bacterial-host interactions. Simulation studies have identified novel 




resemble host ligands on receptors44. Moreover, simulation of receptor N-glycosylation 
has strengthened our understanding of host cell manipulation by parasites such as 
Trypanosoma brucei45. However, little information is available on interaction of bacterial 
virulence factors with N-glycosylated host receptors.  Indeed, molecular simulation studies 
of an N-glycosylation protein with a protein ligand had not been attempted previously.  Thus, 
our study introduces a novel method of integrating molecular modeling and experimental 
evidence to predict the protein-protein interface of OmpA with glycosylated FcγRIa. This 
predicted structure presents an atomistic detail of the interactions that provide a mechanistic 
understanding of one aspect of the bacterial invasion process in neonatal meningitis. It can 
also be used to formulate further experimental and computational tests to obtain deeper 
understanding of the interactions of OmpA with the peptide regions of FcγRIa beyond the 
glycosylation portions. This would provide the basis for structure based design of small 
molecule inhibitors to prevent E. coli K1 interaction with FcγRIa, thereby preventing the 





C h a p t e r  3  
THE INTERACTION OF NATURAL SWEETENER STEVIA GLYCOSIDES WITH 
HUMAN BITTER TASTE RECEPTORS TAS2R4 AND TAS2R14 
 
Abstract 
Steviol glycosides, the sweet principle of Stevia Rebaudiana (Bertoni) Bertoni, have recently 
been approved as a food additive in the EU. The herbal non-nutritive high-potency 
sweeteners perfectly meet the rising consumer demand for natural food ingredients in 
Europe. Experiments have revealed that two human bitter taste receptors, hTAS2R4 and 
hTAS2R14, mediate the bitter off-taste of steviol glycosides. We computationally predicted 
the structures of the transmembrane domain of these two receptor and how various agonists, 
including steviol glycosides, bind to the binding sites. From the structural insights and 
statistical analysis of the sugar number distribution on two sides of the steviol glycosides, we 
proposed an activation mechanism of how steviol glycosides activate these two bitter 
receptors. These results might contribute to the prediction of preferentially least bitter tasting 






The mammalian taste sensation provides valuable information about the nature and 
quality of food. Taste transduction involves the interaction of tastant molecules with taste 
receptor-expressing cells that reside in the taste buds located on the papillae of the 
tongue. Taste buds relay information to the brain about the nutrient content of food. At 
present, there are five basic tastes, sweet, salt, sour, umami, and bitter, and among these, 
sweet, umami, and bitter taste sensations are sensed by G-protein-coupled receptors 
(GPCRs)46. 
Human bitter taste receptors (T2Rs) that reside in the taste buds of the tongue are 
responsible for bitter taste perception, but they are also found in other parts of the body, 
playing important roles for nutrient sensing in the gut and in the regulation of metabolic 
processes, which makes them potential therapeutic targets for disease 47,48. T2Rs are non-
Class A members of the GPCR superfamily, with very limited structural information. 
Despite extensive studies, the precise mechanisms of GPCR activation are still poorly 
understood. 
Steviol glycosides, a class of non-nutritional and natural sweetener49, have bitter 
aftertaste due to its agonicity towards human bitter receptors 2R4 and 2R1450. Based on 
molecular docking results of several agonists including rubusoside to our predicted 
structures of 2R4 and 2R14 transmembrane (TM) helical bundle, we proposed an 
activation mechanism of these two receptors that could explain the bitterness of steviol 
glycosides. Our activation model leads to a selection rule that could qualitatively predict 




3.2 Simulation Details 
We used our GEnSeMBLE method51–55 to predict an ensemble of 25 low energy 
structures for each of 2R4 and 2R14 receptors. The structure of 2R4 is based on the 
homology model of the turkey Beta1 adrenergic receptor X-ray crystal structure56 with 
40.7% sequence similarity. The structure of 2R14 is based on the homology model of the 
human dopamine D3 X-ray crystal structure57 with 39.6% sequence similarity. For each 
of the two bitter receptors, the helix shapes were optimized within their respective 
template, sampled all (12)7 = 35 million rotations of each of the seven helices 
independently, followed by sampling of 13 trillion combinations of helix rotations and 
tilts to select by neutral inter-helical energy the best conformation of the seven helix 
bundles. 
We then docked various known agonists to the best conformation of the seven helix 
bundle for each receptor. To obtain a diverse set of ligand conformations for docking, we 
generated a total of 10 ligand conformations for each ligand. The molecular structures of 
the ligands were constructed with Maestro software or constructed from existing 
coordinates from the crystallized structures deposited in the Cambridge Structural 
Database. A conformational search was performed with MacroModel software. Sytematic 
and extended torsional sampling options were used where the selected rotatable bonds are 
rotated 360° in 30° increments. Ligand conformations that fall within an energy window 
of 10 kcal/mol and an RMSD diversity of 0.5 Å were saved for subsequent steps. The 
conformational search was conducted with the OPLS 2005 force field58 and in a dielectric 
of 80.37 to match water. Subsequently, we performed two rounds of clustering for each 




round of clustering with a 1.0 Å diversity. The Mulliken populations of each atom were 
calculated with Jaguar software59 using Density Functional Theory (DFT) with the 
B3LYP functional and the 6-31G** basis set. This led to the selection of 10 ligand 
conformations. Each ligand was minimized using the Surface Generalize Born (SGB) 
solvation model60 for 100 steps or to a convergence threshold of 0.2 kcal/mol/Å RMS 
force with the MPSim program61. For each of the ten conformations of a ligand, we used 
the DarwinDock and GenDock51,62–65 methods to predict the optimum binding site for 
each of the lowest energy protein structures predicted by GEnSeMBLE for the 2R4 and 
2R14 receptors. 
 
The DarwinDock method aims at generating a complete set of poses for the binding 
pocket while using RMSD clustering of the poses to dramatically reduce the 
computational cost. To provide flexibility and space for the ligand to identify favorable 
binding sites, we replaced the seven bulky hydrophobic residues (FILMYVW) with 
alanines. The mutated residues are called alanized residues, and the mutated protein is 
called alanized protein. For each of the best 100 ligand poses in the alanized protein, we 
then dealanized the mutated residues back to their original hydrophobic identity and 
optimized their positions along with those of other residues in the binding site using 
SCREAM66. This leads to a unique set of optimized residue side chains for each of the 
100 ligand poses. 
 
In the pose generation step of DarwinDock, a ligand pose is acceptable if it clashed or 




5,000 ligand poses (without evaluating an energy) and clustered them into families, 
where every family member is within a 2.00 Å RMSD of each other. Then, we added 
5,000 more ligand poses from Dock6 and reclustered. This procedure of adding 5,000 
poses and reclustering is repeated until the number of new families generated is less than 
2% of the total number of families in the preceding iteration. Typically, 45,000 poses 
were generated leading to 6000−9000 2.0 Å families. At this point DarwinDock scores 
the energies of one representative from each family, the family head, and selects the 10% 
of family heads with the lowest Dreiding energies. All members of these respective 
families are then scored energetically. From this list of approximately 5000 poses, we 
select the lowest 50 by each of three criteria: lowest hydrophobic energy, lowest polar 
energy, and lowest total energy, giving at most 150 poses. 
 
GenDock was used to refine the 150 docked ligand−receptor poses generated by 
DarwinDock. In the SCREAM step, “alanized” residues were replaced with the original 
hydrophobic residues but using the optimum side chain rotamers to avoid any clashes 
with the ligand and other protein side chains. Then the entire complex was minimized for 
10 steps for each case to remove any bad contacts. Next, the receptor was neutralized, so 
that the acidic residues (aspartic acid and glutamic acid) each gained a proton, and the 
basic residues (lysine and arginine) each lost a proton. The resulting receptor−ligand 
complexes were minimized for 60 steps using the Dreiding III FF. Then for each of the 
ten ligand conformations, we selected the lowest binding energy structure, including 
strain and ligand solvation, which we expected to best represent the binding affinity. The 




between the complex and the sum of the receptor and ligand energies with ligand strain 
and ligand solvation included. The selected complex was minimized with the Dreiding III 
FF with the LJ vdW term (Dreiding III-LJ FF) in vacuum for 50 steps or to an RMS force 
threshold of 0.5 kcal/mol/Å using the MPSim program. 
 
3.3 Results and Discussion 
Our prediction of the 2R4 and 2R14 transmembrane (TM) bundle structures suggested 
that the inactive protein conformations are characterized by interactions between the 
intracellular end of TM helices 3 and 6 (IC-TM 3-6 coupling), and IC-TM 2-6 coupling, 
as highlighted in Figures 3.1 and 3.2. The IC-TM 3-6 couplings through hydrogen 
bonding in both 2R4 and 2R14 are similar to the intracellular 3-6 “ionic lock” observed 
as an characteristic salt-bridge in Class A GPCRs68,69. The IC-TM 2-6 couplings are 
similar to the predicted and experimentally validated intracellular 2-6 salt-bridge in CB1 









































Figure 3.1: Predicted TM bundle structure of TAS2R4. TM3-6 coupling interactions 





By docking various known agonists to the TM binding sites of the two receptors, we 
could validate the accuracy of the predicted binding sites. The results showed that 
agonists binding changes the conformations of several key residues in the binding site, 
yielding strong TM 3-6 and 2-6 couplings in the mid-TM binding site as shown in 
Figures 3.3 and 3.4, which could potentially break the intracellular TM 3-6 and 2-6 
couplings and thus lead to activation. This mechanical view of coupled helical motions 







































Figure 3.2: Predicted TM bundle structure of TAS2R14. TM3-6 and TM2-6 

















Our prediction of the binding interactions of rubusoside with 2R4 and 2R14 provided a 
key insight on how the whole class of steviol glycosides binds to 2R4 and 2R14. As 
shown in Figure 3.5 (left), a steviol glycoside molecule comprises three parts: a stevia 















































Figure 3.3: Predicted structure of 2R4 bound with its agonist parthenolide. 
Binding of an agonist strengthens TM3-6 coupling in the binding site of 2R4. 
Figure 3.4: Predicted structure of 2R14 bound with its agonist aristolochic acid. 
Binding of an agonist breaks TM2-3 coupling and forms TM3-6 and TM2-6 




representation of the molecule is further simplified in Figure 3.5 (right). Rubusoside 
binds to 2R4 and 2R14 with the A side (one glucose) inserted into the TM binding site 
facing towards the intracellular end, while the B side (one glucose) is facing the 
extracellular end, as shown in Figures 3.6 and 3.7. The A side directly interacts with the 
key residues at the bottom of the binding site and mediates TM 3-6 and 2-6 couplings 
within these residues.  
















































Figure 3.6: Predicted structure of 2R4 bound with rubusoside. Binding of rubusoside 










We observed that the 11 steviol glycoside molecules reported in reference 71 all have 
group A (0-2 monosaccharides) smaller than or equal to their group B (1-3 
monosaccharides). Due to the spatial constraint of the funnel-like shape of the TM 
binding site, we proposed that this A-down-B-up binding model is general for the whole 


























Figure 3.7: Predicted structure of 2R14 bound with rubusoside. Binding of rubusoside 






































































































Figure 3.8: Histogram of (COOH sugar #, OH sugar #) distribution of 94 molecules in 
Cargill priority list 1. Molecules in the red box except RebM and RebN are predicted to be 












Given two lists of stevia glycosides from the Cargill company, we did further analysis on 
a total number of 94 entries in priority list 1 and 151 entries in priority list 2. We first did 
a statistical analysis on how the stevia glycosides in each list distribute in a two-
dimensional histogram where the x-axis is the number of sugar groups (monosaccharides) 
on the –COOH side and the y-axis is the number of sugar groups on the –OH side, as 
shown in Figure 3.8 for priority list 1 and Figure 3.9 for Priority list 2. The number in a 
box of coordinate (x, y) is the number of entries in a list with x sugars in group A and y 
sugars in group B (Figure 3.5). As mentioned, stevia glycosides tend to have more sugar 





























































































Figure 3.9: Histogram of (COOH sugar #, OH sugar #) distribution of 151 molecules in 
Cargill priority list 2. Molecules in the red box (not including RebM and RebN) are 




10 stevia glycosides with experimental bitterness measurement from Cargill onto the 
histogram and color-coding them by their relative bitterness, we found that the more 
sugar groups on either the –COOH side or the –OH side, the less bitter a stevia glycoside 
is. This statistical trend suggested that the 23 molecules in the red box in the two 
histograms would be on the less bitter end of the bitterness spectrum.   
This statistical observation could be explained by the structural insight we obtained from 
modeling. The glycan on the –COOH side with more sugar groups is difficult to fit into 
the binding pocket and form strong interactions with the two residues that couple TM3-6 
in the binding site. The glycan on the –OH side with more sugar groups will have 
stronger interactions with the flexible extracellular loop region, which prevents the whole 
ligand from reaching deeper into the bottom of the binding site where the two residues 
couple TM3-6. These two interpretations lead to two hypothetical rules to select the best 
candidates with the least bitterness. Rule #1 says that a large group B on the –OH side 
would lead to less bitterness, as explained by Figure 3.10. According this rule, 2 
molecules in the Priority 1 list and 1 molecule in the Priority 2 list with coordinate 
(3COOH, 4OH) will be among the best targets for low bitterness. Rule #2 says that a large 
group A on the –COOH side would lead to less bitterness, as illustrated in Figure 3.11. 
Thus the 2 molecules in the Priority 2 list with coordinate (4COOH, 2OH) will be among the 



















































Figure 3.10. Rule #1 for selecting low bitter targets. If –OH sugar group (group B) is large, it 
will be held by the loop region, making the –COOH sugar group difficult to form stable 































We predicted the structures of 2R4 and 2R14 and how various ligands including stevia 
glycosides with diversity in structure and bitterness bind to these two receptors. We also 
distilled the key insight on activation mechanism from these structures and came up with 
qualitative criteria which could potentially predict the relative bitterness of 
experimentally untested stevia glycosides. Given two lists of stevia glycosides with a 
total number of 235 entries from the Cargill company, we predicted that 23 out of 235 



















Figure 3.11. Rule #2 for selecting low bitter targets. It is difficult for large –COOH sugar 
group (group A) to fit into the binding site and form stable interaction with the two residues 









C h a p t e r  4  
REACTION MECHANISMS OF METHANE OXIDATION BY THE BIOMIMETIC 
TRICOPPER CLUSTER COMPLEXES 
 
Abstract 
We report QM studies of the reaction mechanism for biomimetic tricopper complexes to 
convert methane to methanol after activation of O2. Based on analyses of particulate methane 
monooxygenase (pMMO), Chan and coworkers developed biomimetic tricopper complexes 
that carry out efficient oxidation of methane to methanol after activation by dioxygen. We 
used density functional theory (DFT) and wavefunction based methods (CASSCF) to 
determine the reaction mechanisms of these tricopper complexes for the entire 
thermodynamic cycle, which consists of (a) C-H bond activation, (b) sacrificial reduction of 
H2O2, and (c) regeneration of the active tricopper cluster by O2 or H2O2. Our results reveal 
that the facile methane oxidation is mediated by transformations between various structural 
and spin states of the tricopper cluster. Analyses of the electronic structures and energetics 
of the spin-state surfaces along the reaction pathway provide detailed reaction mechanisms 







The activation and functionalization of an inert C-H bond of alkane molecules is a great 
challenge for both scientific and industrial communities, because alkanes are the main 
constituents of natural gas and an efficient way of such transformation of alkanes to 
liquid fuels like alcohols could have a direct economic impact71–73. For the strong C-H 
bond (~100 kcal/mol) in methane, the current industrial chemical processes require 
extreme conditions which are costly and inefficient, due to the fact that the inertness of 
the strong C-H bond requires significant energy for both the homo- and hetero-lytic C-H 
bond cleavage. Oxygenation of the C-H bonds in alkanes, especially methane oxidation 
to produce methanol, still remains as a challenging problem74. 
However, methanotrophic bacteria accomplish this feat readily under ambient conditions 
using metalloenzymes called methane monooxgyenases (MMOs)75. The MMOs catalyze 
oxidation of methane to methanol utilizing O2 and two reducing equivalents from 
NAD(P)H or quinols to split the O-O bond. One oxygen atom of the O2 is incorporated 
into the hydrocarbon substrate to yield methanol and the other oxygen atom is reduced to 
water with the uptake of two protons. Two types of MMO enzymes are found in 
methanotrophic bacteria: the soluble form (sMMO) present in the form of a cytoplasmic 
complex76,77, and particulate MMO (pMMO) which is in membrane-associated form78.  
While it is now well established that in sMMO the activation of methane takes place in a 
diiron active site with possible mechanisms figured out from spectroscopic measurements 




by pMMO partially due to a long-standing lack of detailed information regarding its 
structure. The first x-ray crystal structure of pMMO was isolated and purified from 
Methylococcus capsulatus (Bath), and reported by the laboratory of Amy Rosenzweig in 
200579. According to this work, the protein crystallizes as a trimer of αβγ monomers with 
three copper ions and one zinc ion per monomer. A ribbon diagram of the structure is 
shown in Figure 4.1, with different colors used to depict the three subunits. PmoA and 
PmoC are mostly transmembrane, each with approximately six transmembrane segments. 
The N- and C-terminal subdomains of PmoB are exposed to the cytosol and are anchored 
at the water-membrane interface by two α-helical 10 transmembrane segments inserted 
into the membrane. The three copper ions and the zinc ion reported in the crystal 
structure are also shown in Figure 4.1, with the three copper ions at site A and site B in 
blue and the zinc ion at site C in brown. Highlighted in the transmembrane domain of the 
crystal structure at site D is a cavity consisting of a hydrophilic cluster of potential metal-
ligating residues, including His38, Met42, Met45, Asp47, Trp48, Asp49, and Glu100 
from PmoA and Glu154 from PmoC. This “cluster of hydrophilic residues” has been 
discounted as a metal-binding site. However, the electrostatic energy of sustaining this 
cavity would be extremely high without metal counter-ions to balance the negative 
charges of the hydrophilic residues. The metal ions must have been stripped away from 





Figure 4.1: Left: the X-ray crystal structure of pMMO isolated and purified from 
Methylococcus capsulatus (Bath). Top right: tricopper cluster modeled as 
Cu(II)Cu(II)Cu(II) with capping “oxo” at site D of the crystal structure. Top bottom: the 
designed ligand environment of a given tricopper complex. 
 
Assuming that the overall fold of the protein structure has not been dramatically 
compromised by the loss of the copper ions, attempts have been made to rebuild the 
coppers back into the protein scaffold81. This effort has led to a tricopper cluster at site D 
(Figure 4.1). The ligands to the copper atoms in the model are as follows: PmoC Glu154 
and PmoA His38 for Cu1; PmoA Met42 and Asp47 for Cu2; and PmoA Asp49 and 
Glu100 for Cu3. In building this model, the Cu(II)Cu(II)Cu(II) cluster is assumed to be 




transmembrane segments inserted into the membrane. This protein architecture is consistent with 
the membrane topology predicted earlier by protease digestion of membrane fragments followed 
by mass fingerprinting of the peptides released by MALDI-TOF-MS.37 The three copper ions 
and the zinc ion reported in the crystal structure are also shown in Figure 2, with the three 
copper ions at site A and site B in blue and the zinc ion at site C in brown. Highlighted in the 
transmembrane domain of the crystal structure at site D is a cavity consisting of a hydrophilic 
cluster of potential metal-ligating residues, including His38, Met42, Met45, Asp47, Trp48, 
Asp49, and Glu100 from PmoA and Glu154 from PmoC. This “cluster of hydrophilic residues” 
has been discounted as a metal-binding site. However, the electrostatic energy of sustaining this 
cavity would be extremely high without metal counter-ions to balance the negative charges of the 
hydrophilic residues. The metal ions must have been stripped away from site D during the 
purification of the protein for crystallographic analysis.45 Repeat of the purification procedures 
adopted by the Northwestern group indicates that as many as 12 of the ca. 15 copper ions are 
removed from the protein during the ammonium sulfate fractionation with concomitant loss of 
enzymatic activity37 (Table 1). The protein preparation on which the X-ray crystal structure has 
been obtained exhibits essentially no pMMO activity.  
 
Figure 2. Architecture of pMMO isolated and purified from Methylococcus capsulatus (Bath) 
according to the X-ray crystal structure of Lieberman and Rosenzweig. (Adapted from Reference 
35.) 
D. The case for the tricopper site.  
Based on the X-ray structure, Rosenzweig and co-workers have ruled out the possibility of a 
tricopper cluster in the enzyme.35,47 There are now additional spectroscopic data to reinforce the 
idea that this tricopper cluster is indeed missing from the X-ray structure."First, the isotropic EPR 
signal attributed to the putative CuIICuIICuII cluster have now been resolved from the type 2 CuII 
signal by redox potentiometry/EPR.39 As noted earlier, these copper sites have distinct redox 




Assuming that the overall fold of the protein structure has not been dramatically compromised by 
the loss of the copper ions, we have made an attempt to rebuild the coppers back into the protein 
scaffold.39 This effort has led to a tricopper cluster at site D (Figure 3). The ligands to the copper 
atoms in the model are as follows: PmoC Glu154 and PmoA His38 for Cu1; PmoA Met42 and 
Asp47 for Cu2; and PmoA Asp49 and Glu100 for Cu3. The CuIICuIICuII cluster is also capped 
with a µ-oxo (O2−) to ensure electrical neutrality at the site. The coordinated ligands and the 
geometry of the cluster, including the Cu−Cu and Cu−O distances, are all reasonable 
demonstrating the feasibility of pMMO to accommodate a tricopper cluster. The trinuclear 
CuIICuIICuII structure modeled here would correspond to that"of the fully oxidized cluster after 
turnover by dioxygen in the absence of hydrocarbon substrate, the so-called “dead-end” 
species.38 "
"
Figure 3. Tricopper cluster modeled as CuIICuIICuII with capping “oxo” at site D of the crystal 
structure. The amino acid side chains coordinating the three copper ions are as follows: Cu1, 
PmoA His38 and PmoC Glu154; Cu2, PmoA Asp47 and Met42; Cu3, PmoA Asp49 and Glu100. 
(Taken from Reference 39.) 
E. The hydrocarbon substrate binding site.  
To account for the substrate specificity of pMMO, not to mention the unprecedented regio-
specificity and stereo-selectivity observed for the alkane oxidation and alkene epoxidation, there 
must be a unique hydrocarbon substrate-binding site in the enzyme in close proximity to the site 
of oxidation of the substrate. In a concerted mechanism of hydroxylation of a C−H bond, for 
example, the substrate must form a complex to allow the O-atom “harnessed” by the activated 
tricopper cluster to become inserted across the C−H bond in the transition state. This criterion 
has been exploited t  locate the hydroxylation site in the enzyme.32  
pMMO Tricopper cluster active site in MMO 
to their corresponding alcohols and ketones with high
efficiencies at room temperature. In these studies, we have
used H2O2 to activate the CuICuICuI complex to its [CuIIC II-
(m-O)2Cu
III(7-N-Etppz)]1+ catalytic intermediate as well as to
regenerate the spent catalyst for multiple turnovers, as we
have previously done with other tricopper complexes in the
oxidation of cyclohexane, be zene, and styrene.[4, 5] The
catalytic cycle becomes more economical if the tricopper
catalyst is activated with H2O2 in lieu of O2 when the substrate
is sufficiently soluble in the solvent to favor O-atom transfer
over competitive reductive abortion of the activated catalyst
at the higher concentration of H2O2 used.
[4] Space-filling and
ball-and-stick models of the structure of [CuIICuII(m-O)2-
CuIII(7-N-Etppz)]1+ intermediate optimized by the semi-
empirical PM6 method are shown in Figure 3 together with
a depiction of the singlet oxene transfer across one of the
C!H bonds in methane.[3]
To underscore the significance of the above results with
respect to the putative tricopper cluster in the pMMO
enzyme,[9] we have prepared a tricopper peptide complex
based on the HIHAMLTMGDWD fragment of PmoA that
lines the empty hydrophilic cavity at the D site in the X-ray
crystal structure of the pMMO purified from Methylococcus
capsulatus (Bath)[10] and have shown that it is capable of
mediating facile methane oxidation at room temperature as
well. The HIHAMLTMGDWD peptide binds three copper
ions to form CuICuICuI- and CuIICuIICuII-peptide complexes
in the presence of excess acetate or chloride (but not nitrate
or sulfate). Both complexes are insoluble in aqueous buffer.
The CuIICuIICuII-peptide complex forms a blue precipitate,
and the precipitate for the CuICuICuI-peptide complex is
white. The copper contained in each peptide is 3.00" 0.05
Cu atoms for the CuIICuIICuII-peptide complex and 3.08"
0.09 Cu atoms for the CuICuICuI-peptide complex, as deter-
mined by inductively coupled plasma optical-emission spec-
trometry (ICP OES). Fast atom bombardment mass spec-
trometry (FAB-MS) of the CuICuICuI-peptide complex
Figure 2. A) Productive cycling and B) abortive cycling in the oxidation
of methane by O2, mediated by the Cu
ICuICuI(7-N-Etppz)1+ complex in
the presence of H2O2 as the sacrificial reductant. BDE= bond dissoci-
ation energy.
Figure 3. Space-filling model (left) and ball-and-stick model (right) of
the optimized structure of [CuIICuII(m-O)2Cu
III(7-N-Etppz)]1+ showing
the funnel-like opening or cleft at the bottom for a hydrocarbon
substrate to access the “hot” oxene group. H white, Cgray, Nblue,
O red, Cubrown. Formation of the transition-state complex during
facile singlet oxene transfer to methane from a dioxygen-activated
tricopper complex is shown at the bottom.
Figure 1. Methane oxidation by O2, mediated by the tricopper
CuICuICuI(7-N-Etppz)1+ complex. A) Formation of methanol was ana-
lyzed by GC (retention time: 5.5 min); inset: assignment of the
product peak to CH3OH was verified by GC–MS, comparing the mass
distribution with that of a CH3OH standard. B) The time course of
methane oxidation; inset: pseudo first-order kinetic plot with rate
constant k1 = 0.0646 min
!1 (C0 = initial concentration of the fully
reduced tricopper complex; C =concentration of methan l produced
at any given tim ), with the best straight-line fit to the data. C) Left:
Catalytic turnover showing the TON as a function of the equivalents of
H2O2 added to regenerate the spent catalyst; right: time course of
catalytic methane hydroxylation by multiple turnovers of the tricopper
complex in the presence of 20 equivalents of H2O2.
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ligands and the geometry of the cluster, including the Cu−Cu and Cu−O distances, are 
all reasonable demonstrating the feasibility of pMMO to accommodate a tricopper 
cluster. The trinuclear CuIICuIICuII structure modeled here would correspond to that of 
the fully oxidized cluster after turnover by dioxygen in the absence of hydrocarbon 
substrate, the so-called “dead-end” species82. 
Inspired by the proposal that the catalytic site might be a tricopper cluster, a series of 
tricopper complexes have been developed and have been shown to be capable of 
supporting facile catalytic oxidation of hydrocarbons83–85. The oxidation of CH4 mediated 
by the tricopper complex is summarized in Figure 4.2. A single turnover is obtained when 
this Cu(I)Cu(I)Cu(I) complex 3 is activated by excess dioxygen in the presence of excess 
CH4 (Figure 4.2). The reaction is complete within ten minutes, clearly indicating that the 
oxidation is very rapid. In accordance with the single turnover, the kinetics of the overall 
process is pseudo first-order with respect to the concentration of the fully reduced 
tricopper complex. The process can be rendered catalytic by adding the appropriate 
amounts of H2O2 to regenerate the “spent” catalyst 3 after O-atom transfer from the 





Figure 4.2: Productive cycling in the oxidation of methane by O2, mediated by the 
Cu(I)Cu(I)Cu(I) complex 3 in the presence of H2O2 as the sacrificial reductant. 
In this work, we investigated the reaction mechanisms the oxygen activation, the methane 
hydroxylation and the sacrificing reduction of H2O2 catalyzed by the tricopper complex 
by quantum chemistry simulations. Density functional theory with B3LYP functionals 
was used to calculate the structures and energies of all the intermediates and transition 
states of the relevant mechanism. The reactivity of different spin states is discussed and 
the wave-function based multireference method, namely Complete Active Space Self 
Consistent Field (CASSCF) is used to investigate the nature of chemical bond of the 
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4.2 Computation Details 
The DFT calculation of the tricopper complex is performed using the Jaguar ab initio 
electronic structure program59, which is a commercial software currently produced and 
maintained by Schrödinger Inc. Keywords in the Jaguar input file is included in the 
parenthesis follow the description of the detailed method for readers who are interested to 
reproduce the results. B3LYP functional16,17 is used combining D3 dispersion 
correction86 (dftname=B3LYP-D3). For geometry optimization, a medium and polarized 
basis set LACVP**87 is used (basis=LACVP**). For single point energies of the 
optimized geometries, a large basis set cc-pvtz(-f)88–91 is used (basis=cc-pvtz(-f)). Both 
geometry optimization and single point energy calculations are done with Poisson-
Boltzmann solvation model (isolv=2, nogas=2) for acetonitrile, which uses a surrounding 
dielectric continuum medium of dielectric constant of 37.5 (epsout=37.5) and probe 
radius of 2.18 (radprb=2.18). The complexes were optimized in the gas phase, and the 
optimized structures were subsequently subjected to a single-point energy calculation 
using the PBF solvation model. Frequencies and thermodynamic contribution to the free 
energy were calculated for the optimized geometries in the gas phase at 373.15 K. The 
reported free energies were calculated by adding the thermodynamic correction, 
including zero-point energy, and the dispersion correction to the single-point solution 
phase energy. The presented transition states (TSs) were verified to have only one 
imaginary frequency and were verified to be connected to the presented succeeding and 
preceding energy minima, respectively. All stationary minima were verified to have no 
imaginary frequencies. The Complete Active Space Self Consistent Field (CASSCF) 




single point energy. 
The accuracy of DFT calculations on the multinuclear copper oxygen clusters have been 
evaluated by several previous computational studies93–95. Recently, Liakos and Neese 
used highly ab initio correlated methods, including relativistic and solvation effects, to 
show that the bis(µ-oxo)Cu(III)2 is in fact more stable than (µ-η2:η2-peroxo)Cu(II)2, in 
agreement with the experimental results96. Furthermore, Liakos and Neese also 
investigated the performance of different exchange–correlation functionals to describe 
the relative energies involved in the peroxo–bis-oxo isomerization and found that the 
B3LYP-D functional presented the best agreement with the LPNO-CCSD results. The 
mean absolute error computed for the deviation of the B3LYP results in relation to 
LPNO-CCSD was 4.4 kcal/mol. The summary of these results shows that the use of 
B3LYP functional including dispersion effects provides relative energies in reasonable 
agreement with correlated ab initio methods. Application of highly correlated ab initio 
methods for studies involving bioinorganic systems still remains challenging, mainly 
with respect to the computational demand required. Therefore, DFT methods remain as 
the main choice for investigations of biological systems of moderate size. The results 
reported by Liakos and Neese support the B3LYP functional including dispersion effects 
as a good computational method for studies involving trinuclear copper complexes like 
the one investigated here. 
4.3 Results and Discussions 
4.3.1 The oxygen activation 




cycle was drawn from a derivative of the interested ligand and its geometry was 
minimized as the starting point of investigating the species involved in the reaction cycle 
(Figure 4.3). The central Cu(I) has a coordination number of 4 with a tetrahedral 
configuration. The bottom two Cu(I)s have a coordination number of 3 and could bind 
the solvent molecule acetonitrile to saturate their coordination. Upon adding a triplet 
dioxygen molecule 3Å away from the the bottom two coppers in such non-bonding 
distance from the complex 3, further geometry optimization of ~140 minimization steps 
yielded a stable intermediate state 1b, where the O-O bond decreased from 1.21Å to 
1.33Å and the distance between the bottom two coppers decreased from 5.41 Å to 5.14 
Å. The change of these bond lengths and the analysis of the molecular orbitals showed 
that one electron transferred from the Cu(I)Cu(I)Cu(I) cluster to the dioxygen, partially 
breaking the O-O bond and leaving only one of the two antibonding pi orbitals of the 
dioxygen that is perpendicular two the plane where the three coppers reside singly 
occupied. Spin density analysis showed that the other unpaired spin mainly resides on the 
central copper, making it a 5-coordinated Cu(II), while the bottom two coppers are 4-
coordianted Cu(I)s. The electronic binding affinity of O2 in the nonbonding distance to 
the state 3 in the initial van der Walls complex is -7.7 kcal/mol. The electronic energy 
decrease from the van der Waals complex to the state 1b is -24.9 kcal/mol, which could 
pay for the 15 kcal/mol entropy penalty of stabilizing molecular oxygen in gas phase 




Figure 4.3: Dioxygen activation of the Cu(I)Cu(I)Cu(I) complex 3 to form the 
Cu(I)Cu(I)Cu(II)(superoxo) species 1b. 
 
Further decrease of the distance between the bottom two coppers from 1b will fully break 
the O-O bond and form a stable state 1a through a barrier of 12.9 kcal/mol (electronic 
energy) on the triplet surface (Figure 4.4). At the geometry of state 1b, the quintet energy 
is 84.3 kcal/mol (electronic energy) higher than the triplet energy. At the geometry of 
state 1a, the quintet energy is 1.2 kcal/mol (electronic energy) lower than the triplet 
energy. As the distance between the bottom coppers decreases from 1b to 1a, the quintet-
triplet gap decreases and undergoes a spin-crossing close to 1a. The quintet state of 1a 




stabilized by the exchange interactions with there same spin electrons in the Cu(II)s.  
 
Figure 4.4: Transformation from Cu(I)Cu(I)Cu(II)(superoxo) species 1b to 
Cu(II)Cu(II)Cu(II)(oxygen radical) species 1a.  
 
To confirm that this small energy gap between the triplet and quintet states at 1a 
geometry is not an artifact of the broken-symmetry property of the DFT calculation used 
for the triplet state, we carried out Complete Active Space Self Consistent Field 
(CASSCF) calculation. For the 4 electrons in 4 orbitals (4e/4o) calculation which uses the 
localized highest energy alpha-spin orbitals from the quintet state DFT calculation, two 
separate CASSCF calculations were performed, converging to the lowest triplet and 
quintet states respectively. The energy of the lowest triplet state from the calculation 




state from the calculation converging to that state. A larger active space calculation 
with 18 electrons in 11 orbitals (18e/11o) was performed converging to the lowest quintet 
state. The energy of the lowest triplet state is 0.049 kcal/mol higher than the lowest 
quintet state from the same calculation. These two CASSCF calculations confirmed the 
near-degeneracy of the low lying quintet and triplet states, revealing that the quintet 
ground state is stabilized by the exchange energy of the 4 unpaired electron with the same 
spin (Figure 4.5). 
 
Figure 4.5: The four natural orbitals from 4 electrons in 4 orbitals CASSCF calculation 





4.3.2 The methane activation 
Both the triplet and quintet states of 1 have a radical character on the bottom oxygen. 
This O-radical is stabilized by the exchange interaction with the unpaired electron with 
same spin on the two bottom Cu(II)s. Binding an equivalence of CH4 gives a free energy 
decrease of 13.3 kcal/mol from separate 1 and gas phase CH4 (MC0) to a van der Waals 
complex between 1 and CH4 (MC1) on the triplet surface and 13.8 kcal/mol on the 
quintet surface (Figure 7). The next step is the hydrogen atom abstraction by the bottom 
O-radical through a linear O-H-C transition state. The free energy barrier for this step is 
11.5 kcal/mol for the triplet surface and 11.3 kcal/mol for the quintet surface. After the 
hydrogen atom transfer, the methyl radical forms a van der Waals complex with the O-
radical quenched compound (MC2), where the newly formed O-H bond points towards 
the methyl radical. In the next step, the O-H bond formed in the previous hydrogen atom 
transfer step reverses its direction, going through a barrier of 10.8 kcal/mol on the triplet 
surface and that of 10.7 kcal/mol on the quintet surface, forming a van der Waals 
complex with the O-H bond pointing away from the methyl radical (MC3). On the triplet 
surface, the methyl radical could rebound to the –OH group in the compound, go through 
a barrier of 6.2 kcal/mol and end up with a neutral methanol product coordinated on one 
of the bottom coppers (MC4t). On the quintet surface, however, the singlet coupling 
between the methyl radical and the –OH group is energetically unfavorable, as MC4q is 
~80 kcal/mol higher than MC4t. The triplet and quintet surfaces undergoes another spin 
crossing between TS2 and MC2. The quintet surface goes up to a thermally inaccessible 
energy level for the temperature of the reaction condition. This shows that the methyl 




the triplet surface, though the earlier hydrogen abstraction and the -OH bond inversion 
steps could happen on both surfaces.  
 
Figure 4.6: Free energy profile of the methane activation at the B3LYP-D3 level of 
theory. The values in are given in kcal/mol and were obtained relative to the quintet state 
of the 1a with separate a methane molecule.  
 
 
4.3.3 Hydrogen peroxide activation 
After the methanol product dissociates from the complex in the previous step, the 
tricopper compound still has two remaining oxidizing power.  An equivalence of H2O2 




reduced Cu(I)Cu(I)Cu(I) state 3 and an equivalence of H2O and O2. The energies in 
Figure 9 are enthalpies comparing to the separate compound 3, H2O and O2.   
In PC1, H2O2 bound to the tricopper compound through a hydrogen bond after methanol 
dissociation. The complex then undergoes the first hydrogen atom transfer through a 
barrier of 4.0 kcal/mol (TS4). The intermediate from the first hydrogen transfer PC2 
undergoes an isomerization where the oxygen in the –OH group breaks one of its bonding 
to the right bottom copper and the hydrogen in the –OH group forms a hydrogen bond 
with the –OOH group bound to the right bottom copper. Despite our effort, the transition 
state for this isomerization TS5 is not found. After that, the second hydrogen could 
transfer from the –OOH group to the –OH group through TS6 with a barrier of 2.4 
kcal/mol. The products from the second hydrogen transfer, H2O and O2, could dissociate 
from the tricopper compound, gaining 30 kcal/mol entropy to pay for the lost of -37.9 





Figure 4.7: Enthalpy profile of the hydrogen peroxide activation at the B3LYP-D3 level 
of theory. The values in are given in kcal/mol and were obtained relative to the state 3 
with separate H2O and O2.  
 
4.3.4 Discussion 
The reaction mechanisms of the tricopper complex studies in this work highlighted that 
the active state for C-H activation has a multiradical character where the non-overlapping 
unpaired electrons in the singly occupied dx2-y2 orbitals of each Cu(II) in stabilized the O-
radical with the same spin by exchange interactions. The exchange-stabilized O-radical is 
able to abstract the H-atom in the C-H bond through hydrogen atom transfer and form the 




spin-allowed. This mechanism is different from the the “singlet oxene-insertion” 
mechanism97 proposed by the Chan group who designed the tricopper complex. In 
Chan’s model, the active state is a Cu(II)Cu(II)Cu(III) complex which could activate the 




In this study, DFT calculations at the level of B3LYP-D3 functional were carried out to 
the reaction mechanisms of the methane hydroxylation by a biomimetic tricopper 
complex. The reaction mechanisms involve three key steps: (i) the oxygen activation, (ii) 
the methane activation, and (iii) hydrogen peroxide activation. During the first two steps, 
two potential energy surfaces of the triplet and quintet states undergo spin-crossing twice. 
The first spin-crossing in the oxygen activation is due to the multiradical character and 
the weak coupling between the back Cu(II) and the strongly coupled quartet in the bottom 
dicopper cluster. The second spin-crossing in the methane activation is due to the high 
spin quintet state does not favor the methyl rebound mechanism. Both the O-radical 
hydrogen abstraction followed by methyl rebound mechanism and the previously 
proposed “oxene C-H bond concerted insertion” mechanism are kinetically possible 
based on computational insights. The computational results in this work are not enough to 







C h a p t e r  5  




The activity of Pt-based Karstedt’s catalyst competent for olefin hydrosilylation has been 
explored by computing free energy surfaces for reaction mechanisms composed of 
elementary transformations with literature precedent. Methoxydimethyl(vinyl)silane and 
trimethyl silane were used as model substrates, instead of using most simplified substrates 
of silicon hydrides and siloxo vinyls as in the previous computational studies. An unexpected 
rate-determining step of agostic bond dissociation is found in between the elementary 
reaction steps proposed previously. The regioselectivity of the products are studied. An 
alternative reaction cycle which is kinetically unflavored is proposed. Since little data is 
available on the decomposition or oxidation products of unstable olefin hydrosilylation 







Hydrosilylation reactions (eq 1) are among the most important reactions in silicone and 
siloxane chemistry98. These type of reactions are extensively used to form Si-C bonds, 
with an important application to cross link hydrosiloxanes with vinyl terminated 
dimethylsiloxanes for the production of protective backing surfaces in pressure sensitive 
adhesive labels. The catalysts which could catalyze these type of reactions usually 
involve late transition metals, most notably Pt, Pd, Ni, Rh, and Co 
 
Low valent Pt compounds are typically used for the cross linking. Of these, one of the 
best characterized is Karstedt’s catalyst 2:
 
Karstedt’s catalyst 2 is composed of Pt2[(H2C=CH)(CH3)2SiOSi(CH3)2-(CH=CH2)]3. 
Upon solvation, the bridging ligand is released, yielding the more active form 
Pt[(H2C=CH)(CH3)2SiOSi(CH3)2-(CH=CH2)].  
Chalk and Harrod99,100 proposed a mechanism for platinum catalyzed hydrosilylation 
reactions based on simple elementary steps commonly observed in organometallic 
chemistry, such as oxidative addition and reductive elimination (Figure 5.1, route a with 
green arrows). A variation of the Chalk-Harrod mechanism was also proposed to explain 
the formation of vinylsilanes.101 This modified version assumes that an olefin attacks on 
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The Karstedt-catalyzed hydrosilylation reaction used in curing of silicone release coatings was investigated
using first-principle quantum mechanical techniques (density functional theory) as well as semiempirical
methods to estimate solubility parameters. The results we obtain for the catalytic cycle indicate, in agreement
with experimental results, that hydrosilylation occurs easily at room temperature. The detailed mechanism
we suggest contains the key features of the models previously proposed in the literature by Lewis and Chalk-
Harrod and adds quantitative estimates of reaction energies and barriers. On the basis of the energy profile
for the catalytic cycle in the presence of inhibitor molecules and on solubility parameters for the species
involved in the reaction, we conclude that the role of the inhibitors we considered is to phase-separate the
catalyst from the substrate. The reaction is thus quenched by introducing a microscopic second phase that
interferes with the homogeneous reaction.
1. Introduction
Hydrosilylation reactions (eq 1) are among the most important
reactions in silicone and siloxane chemistry,1 and they are
extensively used as a means to form Si-C bonds. One important
application of these reactions is to cross link hydrosiloxanes
with vinyl terminated dimethylsiloxanes1 for the production of
protective backing surfaces in pressure sensitive adhesive labels.
This often involves catalysis by late transition metals, most
notably Pt, Pd, Ni, Rh, and Co2
Typical catalysts used for the cross linking are low valent Pt
compounds. Of these, one of the best characterized is Karstedt’s
catalyst 23,4
Catalyst 2 is bottled as Pt2[(H2CdCH)(CH3)2SiOSi(CH3)2-
(CHdCH2)]3. Upon solvation, the bridging ligand is released,
yielding the more active form Pt[(H2CdCH)(CH3)2SiOSi(CH3)2-
(CHdCH2)].
The catalyzed hydrosilylation reaction is typically fast at
ambient conditions and, in the case of cross linking polymer-
ization, results in solidification of the substrate. It is hence
common practice to quench the reaction by adding inhibitors
to allow easy handling and storage of the bath as a liquid. Once
the bath is applied to the backing surface support, it is cured
by removing the inhibitor, which activates the cross linking
reaction. Typical curing conditions are 5-20 s at 100-150 °C.
In 1964, Chalk and Harrod5,6,7 proposed a mechanism for
platinum catalyzed hydrosilylation reactions based on simple
elementary steps commonly observed in organometallic chem-
istry, such as oxidative addition and reductive elimination. A
variation of the Chalk-Harrod mechanism was also proposed
to explain the formation of vinylsilanes.2,7 This version assumes
an olefin attack on the Pt-Si bond that has never been observed
experimentally. Although both the original and the modified
Chalk-Harrod mechanisms correctly describe the hydrosilyla-
tion reaction, they fail to account for a number of phenomena
observed mainly at the beginning (induction period) and the
end (change in color) of the reaction.
To explain the induction period, color change, and several
other effects, Lewis proposed in 19868,9 a radically different
mechanism. He suggested that the catalytic species are colloidal
platinum particles rather than organometallic complexes. He
regarded the reaction as a surface, or edge, catalyzed hetero-
geneous process. His original mechanism became known as the
Lewis mechanism. Later, he realized that although most
experiments result in the formation of colloidal particles,
hydrosilylation does not depend on their existence and must
thus be regarded as a homogeneous process.10 When the original
Lewis mechanism is translated from the platinum surface to an
organometallic compound, it becomes similar to the older
Chalk-Harrod mechanism, the main difference being the order
in which different ligands are coordinated and activated.
The structure of several compounds resulting from the
reaction of inhibitor molecules with catalyst 2 are known from
EXAFS or NMR analysis.11 To date, however, no clear model
has been formulated to rationalize the role of the inhibitors. In
particular, the problem of why certain additives are better
inhibitors than others has not been addressed in the literature.
In the next section, we report our computational results for
each of the elementary steps involved in the Chalk-Harrod,
Lewis, and a third, similar, mechanism. On the basis of these
results, we conclude that all three mechanisms represent minor
var ations of the same catalytic cycle and that the activation
energy is small. In the following section, we investigate possible
rol s of the inhibitors and come to the conclusion that inhibitors
cannot block the active site by binding to it. In the fourth section,
we r port the results from solubility simulations of the various
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the Pt-Si bond which has never been observed experimentally. Although both the 
original and the modified Chalk-Harrod mechanisms correctly describe the 
hydrosilylation reaction, they could not account for a number of phenomena observed 
mainly at the beginning (induction period) and the end (change in color) of the reaction.  
To explain the induction period, color change, and several other effects, Lewis proposed 
a different mechanism which suggested that the actual catalytic species are colloidal 
platinum particles instead of organometallic complexes.102,103 The Lewis mechanism 
regarded the reaction as a heterogeneous process that happens at the surfaces, or edges, of 
the Pt colloidal particles. Later, he realized that hydrosilylation does not depend on the 
existence of colloidal particles, though most experiments result in the formation of them. 
When the original Lewis mechanism is translated from the platinum surface to an 
organometallic compound, it becomes a homogeneous process and is similar to the older 
Chalk-Harrod mechanism.104 The main difference of the Lewis mechanism from the 
Chalk-Harrod mechanism is the order in which different ligands are coordinated and 





Figure 5.1: Redox cycles for olelfin hydrosilylation (a-c) and (d) the non-redox cycle 
based on the established mechanisms. 
 
Previous computational studies have investigated each of the elementary steps involved 
in the Chalk-Harrod, Lewis, and an alternative mechanism (Figure 1, route c with red 
arrows), with the most simplified reactants SiH(OH)2 and SiH2OH, where the long chain 
alkyl groups of the substrates are all substituted by hydrogen.105 On the basis of these 
results, it was concluded that all three mechanisms represent minor variations of the same 
catalytic cycle and that the activation energy is small.  
In this work, we used two more realistic substrates sets (Figure 5.2) to computationally 
study the reaction mechanisms involved in the catalytic cycle and tried to explain 
qualitatively the variation of regioselectivity due to the change in the substrates. We also 




Figure 5.1, route d. At last, we looked into the oxygen binding affinity of pre-catalyst 
and the resting state in the reaction cycle to study the atmospheric stability of the catalyst.  
5.2 Computation Details 
The DFT calculations are performed using the Jaguar ab initio electronic structure 
program59, which is a commercial software currently produced and maintained by 
Schrödinger Inc. Keywords in the Jaguar input file is included in the parenthesis follow 
the description of the detailed method for readers who are interested to reproduce the 
results. B3LYP16,17 functional is used combining D3 dispersion correction86 
(dftname=B3LYP-D3). For geometry optimization, a medium and polarized basis set 
LACVP**87 is used (basis=LACVP**). For single point energies of the optimized 
geometries, a large basis set cc-pvtz(-f)88–91 is used (basis=cc-pvtz(-f)). Both geometry 
optimization and single point energy calculations are done with Poisson-Boltzmann 
solvation model (isolv=2, nogas=2) for solvent dichloromethane to mimic the polymer 
matrix environment. The complexes were optimized in the gas phase, and the optimized 
structures were subsequently subjected to a single-point energy calculation using the PBF 
solvation model. Frequencies and thermodynamic contribution to the free energy were 
calculated for the optimized geometries in the gas phase at 373.15 K. The reported free 
energies were calculated by adding the thermodynamic correction, including zero-point 
energy, and the dispersion correction to the single-point solution phase energy. The 
presented transition states (TSs) were verified to have only one imaginary frequency and 
were verified to be connected to the presented succeeding and preceding energy minima, 





5.3 Results and Discussion 
The reaction mechanisms of the Karstedt’s platinum catalyst are modeled using the two 
sets of simplified substrate side-chains, as illustrated in Figure 5.2. For the olefin 
substitution R0 group, set 2 uses trimethoxysilyl group and set 1 uses methoxy(diethyl) 
silyl group. For the silane substrate, set 1 is trimethylsilane, while one of the three methyl 
groups is substituted to a dimethylsiloxy group. Overall, the substrates in set 2 are bulkier 
than the substrates in set 1, representing the local environment of the reaction centers in a 
polymer matrix. Experiments have shown that the bulkier substrate set 2 yields higher 
anti-Markovnikov vs. Markovnikov product ratio than that of substrate set 1, with the 
exact numbers uninformed for this project. 
We compared several competing reaction routes in Figure 1 and found that the sequence 
of silane addition, hydride migration and reductive elimination is kinetically the most 
preferred route. The rate-limiting step of this route is the transition state B in Fig. 2 where 
the agostic bond breaks after hydride migration. This elementary step is not explicitly 
included in the previously proposed mechanisms. The difference in this free energy 
barrier, ΔΔG between Markovnikov and anti-Markovnikov transition states, determines 
the selectivity of the two regioisomers. For substrate set 1, a ΔΔG(M-TM) of 0.7 
kcal/mol gives an AM/M ratio of 77/23 at room temperature. For the bulkier substrate set 
2, a decreased ΔΔG(M-TM) of 0.2 kcal/mol gives a reduced AM/M ratio of 55/45 at 









Figure 5.2: The free energy profile of the Pt(II) reductive elimination route of the 
Karstedt catalyst, using the simplified substrate set 1. The transition state B is the rate 
determining step (RDS) and the difference in free energy between the anti-Markovnikov 
route (black) and the Markovnikov route (red) in state B gives rise to the regioselectivity 


































































































The reaction mechanism is further complicated by several Pt(II) routes and potential 
Pt(IV) routes competing unfavorably with the reductive elimination route, as mapped out 
in Fig. 3. These alternative pathways were only explored for the substrate set 1. Several 
possible reaction mechanisms could be drawn from state F, which is the intermediate 
after the rate-determining agonist bond breaking step. Besides the reductive elimination 
route from F to J to form product, F could have four alternative fates: (i) F undergoes 
silyl migration to the α-carbon of the olefin with transition state L, (ii) F undergoes silyl 
group migration to the β-carbon of the olefin with transition state N, (iii) F binds another 
silane substrate and undergoes hydride migration with transition state M, and (iv) A 
silane exchange with the olefin bound in F and gets activated in P, then hydride transfer 
in transition state Q to form the product. Comparisons between these five routes showed 
that the reductive elimination has the lowest barriers of 24.9 kcal/mol for forming 
Markovnikov product and 20.9 kcal/mol for forming anti-Markovnikov product. The next 
lowest barrier route is from F to Q which is 2.0 kcal/mol higher for Markovnikov product 
and 3.1 kcal/mol higher for anti-Markovnikov product.  
If the reaction goes through the kinetically unfavorable route of transition state Q, the 
product could dissociate and another olefin could bind the Pt catalyst and form the state R 
which is thermodynamically more favorable. The state R could be a sink state once it is 
formed because of the high barrier to get out through the transition state S of silyl 
migration to further cycle through silane activation and hydride migration via transition 





Figure 5.3: The free energy profile of several competing Pt(II) and Pt(IV) reaction routes 
of the Karstedt catalyst, using the simplified substrate set 1. The transition state Q 
involved in activating another silane from the state F has a much higher barrier than the 
transition state D involved in reductive elimination to enter a different turnover cycle 
R->S->U->R via Pt(IV). But the state R could serve as a thermodynamic sink as it is the 
lowest state in free energy among all the calculated states and has a relatively higher 
barrier in the transition state S to make any products. 
 
 
The oxygen sensitivity of the pre-catalyst state A and several resting states are also 
studied, as the examples shown in Fig. 4. The lowest O2 electronic binding energy is -9 
kcal/mol, which could hardly beat ~15 kcal/mol entropy penalty to form a physically-

























































































































Figure 4. (a) The minimized structure of O2 bound Pt(0) pre-catalyst state A. The average 
distance between the dioxygen to the Pt atom is about 3.4Å and the electronic binding 
energy is -5.0 kcal/mol. (b) The minimized structure of O2 bound Pt(II) resting state F. 
The average distance between the dioxygen to the Pt atom is about 3.2Å and the 
electronic binding energy is -8.7 kcal/mol. In both cases the electronic binding energy for 
O2 could not beat the 15 kcal/mol entropy penalty for binding a free O2 molecule. 
 
5.4 Conclusions 
In this study, the major points regarding the mechanism and selectivity of Karstedt’s 
catalyst have been addressed with more realistic substrate sets. It was found that silane 
addition, hydride migration, and reductive elimination is kinetically the most preferred 
route. Between hydride migration and reductive elimination, the agnostic bond dissociation 
step unexpectedly turned out to be the rate-determining step in the reaction cycle. Free 
energy barrier differences between Markovnikov and anti-Markovnikov transition states 
are calculated for the two substrate sets respectively to explain the trend of the change of 
regioselectivity between the two substrate sets. Alternative competing reaction mechanisms 
were also explored outside the cycle of covered by previously studied Chalk-Harrod, 




kinetically unflavored route through silane-olefin coordination exchange, silane 
activation and hydride migration could lead to a thermodynamically stable disilyl 
intermediate. This intermediate could be a thermodynamic sink state under room 
temperature but also cycle through Pt(IV) intermediate to form product under higher 
temperature. The pre-catalyst and the reaction intermediates from the catalytic cycle have 
very weak binding affinity to O2, supporting the experimentally observed O2 stability. 
However, the role of O2 in the alternative reaction cycle undergoing silyl migration with 
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